| Comunicación Nº: 108 | English version  |
| Comunicación Nº: 108 | English version |
Miguel Andújar Sánchez, M. Pavcovich, R. Alamo, L. León, José María de Lera Martínez, Miguel Ángel Sánchez Ramos, J.L. Afonso, R. Camacho, A. López*, O. Falcón*.
[Título] [Introducción] [Material y Métodos] [Resultados] [Iconografía] [Discusión]
|
|
1.- Kurman RJ, Zaino RJ, Norris HJ. Endometrial carcinoma. En: Kurman RJ, ed. Blaustein’s Pathology of the female genital tract. New York: Springer -Verlag, 1994:439-486.
2.- Silverberg SG, Kurman RJ. Endometrial carcinoma. En: Rosai J, de. Atlas of tumor pathology. Tumors of the uterine corpus and gestational trophoblastic disease. Washington: AFIP, 1992:47-89.
3.- Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93-108.
4.- Sherman ME, Bitterman P, Rosenshein NB, DelgadoG, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic feature. Am J Surg Pathol 1992;16:600-610.
5.- Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 1976;37:872-882.
6.- Silverberg SG, DeGiorgi LS. Clear cell carcinoma of the endometrium: clinical, pathologic and ultrastructural findings. Cancer 1973;20:1405-1417.
7.- Kato DT, Ferry JA, Goodman A, Sullinger J, Scully RE, Goff BA, et al. Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases. Gynecol Oncol 1995;59:384-389.
8.- Morrow CP, Bundy BN, Kurman RJ, Cressman WT, Heller P, Homesley et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
9.- Goff BA, Kato DT, Schmidt RA, Ek M, Ferry JA, Muntz HG, et al. Uterine papillary serous carcinoma : patterns of metastatic spread. Gynecol Oncol 1994;54:264-268.
10.- Lampe B, Kurzl R, Hantschmann P. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma. Cancer 1994;74:2502-2508.
11.- Demopoulos IR, Genega E, Vamvakas E, Carlson E, Mittal K. Papillary carcinoma of the endometrium: morphometric predictors of survival. Int J Gynecol Pathol 1996;15:110-118.
12.- Abeler VM, Vergote IB, Kjørstad KE, Tropé CG. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 1996;78:1740-1747.
13.- Carcangiu ML, Chambers JT. Early pathologic stage clear cell carcinomaa and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol 1995;14:30-38.
14.- Abeler VM, Kjørstad KE. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. Gynecol Oncol 1990;39:266-271.
15.- O’Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol 1990;37:112-119.
16.- Rosenberg P, Blom R, Hogberg T, Simonsen E. Death rate and recurrence pattern among 841 stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol 1993;51:311-315.
17.- Lampe B, Kurzl R, Hantschmann P. Reliability of tumor typing of endometrial carcinoma in prehysterectomy curettage. Int J Gynecol Pathol 1995;14:2-6.
18.- Kupryjanczyk J, Thor AD, Beauchamp R, Poremba C, Scully RE, Yandell DW. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin and multifocal disease. Mod Pathol 1996;9:166-173.
|
